Distribution of glyoxalase I polymorphism among Zuni Indians: the Zuni Kidney Project

Journal of Diabetes and its Complications

Volumn 22, Issue 4, 2008, Pages 267-272

  Degaffe, Guenet H ^a   Vander Jagt, David L ^a   Bobelu, Arlene ^b   Bobelu, Jeanette ^a   Neha, Donica ^a   Waikaniwa, Mildred ^a   Zager, Philip ^a   Shah, Vallabh O ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b Dialysis Clinic Inc   (United States)

Author keywords

American Indians; Diabetes; Glyoxalase I gene; Polymorphism; Zuni Kidney Project

Indexed keywords

CREATININE; GENOMIC DNA; GLUCOSE; HEMOGLOBIN A1C; LACTOYLGLUTATHIONE LYASE; METHYLGLYOXAL;

ADULT; AGED; ALBUMINURIA; AMERICAN INDIAN; ARTICLE; BLOOD PRESSURE; CREATININE BLOOD LEVEL; DEMOGRAPHY; DETOXIFICATION; DISEASE DURATION; DNA ISOLATION; FEMALE; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POINT MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEX RATIO; STATISTICAL ANALYSIS; ZUNI INDIAN;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; ALLELES; CREATINE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; LACTOYLGLUTATHIONE LYASE; MALE; MIDDLE AGED; NEW MEXICO; POLYMORPHISM, GENETIC;

EID: 45849120986     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2007.06.010     Document Type: Article

References (34)

1. Allannic H., Fauchet R., Gueguen M., Pheng S.H., Dinh K.T., and Genetet B. Factor B (Bf) and glyoxalase genes in insulin-dependent diabetes mellitus. Diabetes & Metabolism 11 (1985) 22-26
2. Carter J., Wilson R., Sava S., Sinnock P., and Gohdes D. Tribal differences in diabetes: Prevalence among American Indians in New Mexico. Public Health Reports 104 (1989) 665-669
3. Chen F., Wollmer M.A., Hoerndli F., Munch G., Kuhla B., Rogaev E.I., Tsolaki M., Papassotiropoulos A., and Gotz J. Role of glyoxalase I in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 7687-7692
4. Friedman E.A. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications. Diabetes Care 22 Suppl 2 (1999) B65-B71
5. Gale C.P., Futers T.S., and Summers L.K. Common polymorphisms in the glyoxalase-1 gene and their association with pro-thrombotic factors. Diabetes & Vascular Diseases Research 1 (2004) 34-39
6. Junaid M.A., Kowal D., Barua M., Pullarkat P.S., Sklower Brooks S., and Pullarkat R.K. Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor. American Journal of Medical Genetics. Part A 131 1 (2004) 11-17
7. Kim N.-S., Sekine S., Kiuchi N.K., and Kato S. cDNA cloning and characterization of human glyoxalase I isoforms from HT-1080 cells. Journal of Biochemistry 117 (1995) 359-361
8. Kim N.S., Umezawa Y., Ohmura S., and Kato S. Human glyoxalase I: cDNA cloning, expression, and sequence similarity to glyoxalase I from Pseudomonas putida. Journal of Biological Chemistry 268 (1993) 11217-11221
9. Kirk R.L., Ranford P.R., Serjeantson S.W., Thompson A.R., Munirathnam C.S.M., John L., et al. HLA, complement C2, C4, properdin factor B and glyoxalase types in South Indian diabetics. Diabetes Research and Clinical Practice 1 (1985) 41-47
10. Klemm T., and Paschke R. Possible genetic causes for late complications of diabetes mellitus. Medizinische Klinik 95 (2000) 31-39
11. Long T.P. The prevalence of clinically treated diabetes among Zuni Reservation residents. American Journal of Public Health 68 (1978) 901-903
12. McCann V.J., Davis R.E., Welborn T.A., Constable I.J., and Beale D.G. Glyoxalase phenotypes in patients with diabetes mellitus. Australian and New Zealand journal of Medicine 11 (1981) 380-382
13. McCarthy M.I. Growing evidence for diabetes susceptibility genes from genome scan data. Current Diabetes Reports 3 (2003) 159-167
14. Mimura G., Kida K., Matsuura N., Toyota T., Kitagawa T., Kobayashi T., Hibi I., Ikeda Y., Tuchida I., and Kuzuya H. Immunogenetics of early-onset insulin-dependent diabetes mellitus among the Japanese: HLA, Gm, BF, GLO, and organ-specific autoantibodies-The JDS study. Diabetes Research and Clinical Practice 8 (1990) 253-262
15. Miyata T., van Ypersele de Strihou C., Imasawa T., Yoshino A., Ueda Y., Ogura H., Kominami K., Onogi H., Inagi R., Nangaku M., and Kurokawa K. Glyoxalase I deficiency is associated with unusual level of advanced glycation end products in hemodialysis patient. Kidney International 60 (2001) 2351-2359
16. 111Glu polymorphism of glyoxalase I gene. Neuroscience Letters 396 2 (2006, March) 163-166
17. Piskorska D., and Kopieczna-Grzebieniak E. Participation of glyoxalases and methylglyoxal in diabetic complication. Polski Merkuriusz Lekarski 4 24 (1998) 342-344
18. Ranganathan S., Ciaccio P.J., Walsh E., and Tew K.D. Genomic sequence of human glyoxalase-I: Analysis of promoter activity and its regulation. Gene 240 (1999) 149-155
19. Ranganathan S., Walsh E.S., Godwin A.K., and Tew K.D. Cloning and characterization of human colon glyoxalase-I. Journal of Biological Chemistry 268 (1993) 5661-5667
20. Ratliff D.M., Vander Jagt D.J., Eaton R.P., and Vander Jagt D.L. Increased levels of methylglyoxal-metabolizing enzymes in mononuclear and polymorphonuclear cells from insulin-dependent diabetic patients with diabetic complications: Aldose reductase, glyoxalase I and glyoxalase II-A clinical research center study. Journal of Clinical Endocrinology and Metabolism 81 (1996) 488-492
21. Ridderstrom M., and Mannervik B. Optimized heterologous expression of the human zinc enzyme glyoxalase I. Biochemical Journal 314 (1996) 463-467
22. Rotimi C.N., Chen G., Adeyemo A.A., Furbert-Harris P., Guass D., Zhou J., Berg K., Adegoke O., Amoah A., Owusu S., Acheampong J., Eghan K., Oli J., Okafor G., Ofoegbu E., Osotimehin B., Abbiyesuku F., Johnson T., Rufus T., Fasanmade O., Kittles R., Daniel H., Chen Y., Dunstom G., and Collins F.S. A genome-wide search for type 2 diabetes susceptibility genes in West Africans: The Africa America Diabetes Mellitus (AADM) study. Diabetes 53 (2004) 838-841
23. Sale M.M., Freedman B.I., Langefeld C.D., Williams A.H., Hicks P.J., Colicigno D.V., Beck S.R., Brown W.M., Rich S.S., and Bowden D.W. A genome-wide scan for type 2 diabetes in African-American families reveals evidence for a locus on chromosome 6q. Diabetes 58 (2004) 830-837
24. Shah V.O., Scavini M., Stidley C., Tentori F., Welty T., Maccluer J.W., Narva A.S., Bobelu A., Albert C.P., Kessler D.S., Harford A.M., Wong C.S., Harris A.A., Paine S., and Zager P.G. Epidemic of diabetic and nondiabetic renal disease among the Zuni Indians: The Zuni Kidney Project. Journal of the American Society of Nephrology 14 (2003) 1320-1329
25. Shinohara M., Thornalley P., Giardino I., Beisswenger P., Thorpe S.R., Onorato J., and Brownlee M. Overexpression of glyoxalase I in bovine endothelial cells inhibits intracellular advanced glycation endproducts formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. Journal of Clinical Investigation 101 (1998) 1142-1147
26. Silander K., Mohlke K.L., Scott L.J., Peck E.C., Holstein P., Skol A.D., Jackson A.U., Deloukas P., Hunt S., Stavrides G., Chines P.S., Erdos M.R., Narisu N., Conneely K.N., Li C., Fingerlin T.E., Dhanjal S.K., Valle T.T., Bergman R.N., Tuomilehto J., Watanabe R.M., Boehnke M., and Collins F.S. Genetic variation near the hepatocyte nuclear factor-4a gene predicts susceptibility to type 2 diabetes. Diabetes 53 (2004) 1141-1149
27. Stidley C., Shah V., Narva A., Dalton D., MacCluer J., Bobelu A., Scavini M., Welty T., and Zager P. A population based cross-sectional survey of the Zuni Pueblo: A collaborative approach to an epidemic of kidney disease. American Journal of Kidney Diseases 39 2 (2002) 358-368
28. Stidley C., Shah V., Narva A., Kessler D., MacCluer J., and Bobelu A. Zuni Kidney Project: A collaborative approach to an epidemic of kidney disease. Journal of the American Society of Nephrology 14 Suppl 2 (2003) S139-S143
29. Subramanian V.S., Krishnaswami C.V., and Damodaran C. HLA, ESD, GloI, C3 and HP polymorphisms and juvenile insulin dependent diabetes mellitus in Tamil Nadu (South India). Diabetes Research and Clinical Practice 25 (1994) 51-59
30. Thornalley P.J. Population genetics of human glyoxalases. Heredity 67 (1991) 139-142
31. Thornalley P.J. Pharmacology of methylglyoxal: Formation, modification of proteins and nucleic acids, and enzymatic detoxification-A role in pathogenesis and antiproliferative chemotherapy. General Pharmacology 27 (1996) 565-573
32. Thornalley P.J. The enzymatic defence against glycation in health, disease and therapeutics: A symposium to examine the concept. Biochemical Society Transactions 31 (2003) 1341-1342
33. Tokunaga K., Omoto K., Juji T., and Itoh T. Polymorphism of BF, C2, and GLO in Japanese patients with insulin-dependent diabetes mellitus: Confirmation of an increase of BF*FT. Human Genetics 62 1 (1982) 86-88
34. Vander Jagt D.L., and Hunsaker L.A. Methylglyoxal metabolism and diabetic complications: Roles of aldose reductase, glyoxalase I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase. Chemico-Biological Interactions 143-144 (2003) 341-351